Results 121 to 130 of about 6,085 (188)

PS06.06 Immune Checkpoint Markers in Lung Large Cell Neuroendocrine Carcinomas (L- LCNEC) [PDF]

Journal of Thoracic Oncology, 2017
N. Abdel Karim, A. Sendilnathan, I. Eldessouki, M. Orr-Asman, C. Xie, J. Wang, H. Elnakat   +6 more
openaire   +1 more source

Development of an externally controlled trial from a single-arm study to assess first-line immunochemotherapy in advanced large cell neuroendocrine lung carcinomas: a study protocol from the FIRST-NEC GFPC 01-2022 trial. [PDF]

BMJ Open
De Montfort A, Pérol D, Lupo-Mansuet A, Greillier L, Gautier J, Decroisette C, Chabaud S, Arpin D, Odier L.   +8 more
europepmc   +1 more source

Case Report: Clinicopathological features of bladder neuroendocrine neoplasm: a retrospective case series of nine cases and literature review. [PDF]

Front Oncol
Ye X, Chen P, Chen J, Zhang Z, Zhao L, Teng Y, Zhan P, Li X, Zhao J, Wen L, Nie Z, Fu Y, Zuo J, Li H, Li Z, Wang J, Chen B, Wang H, Fu S.   +18 more
europepmc   +1 more source

Clinical practice review of systemic treatment in large cell neuroendocrine carcinoma. [PDF]

Transl Lung Cancer Res
Cass AS, Luckage IC, Linden AG, Ramirez RA.   +3 more
europepmc   +1 more source

Large Cell Neuroendocrine Carcinomas (Lcnec) of the Lung: Pathologic Features, Treatment and Outcomes

Annals of Oncology, 2014
J. Naidoo, M.L. Santos-Zabala, T. Iyriboz, K. Woo, C.S. Sima, J.J. Fiore, M. Kris, S.R. Veach, G.J. Riely, A. Iqbal, S. Smith-Marrone, I.S. Sarkaria, L.M. Krug, C.M. Rudin, N. Rekhtman, M.C. Pietanza   +15 more
openaire   +1 more source

Primary large cell neuroendocrine carcinoma of the breast with metastasis in the lymph nodes: a case report and literature review. [PDF]

Front Oncol
Li H, He M, Zhang H, Yu C, Yang M.
europepmc   +1 more source

Cervical mixed small cell neuroendocrine carcinoma and adenocarcinoma with genital tract dissemination: a case report and literature review. [PDF]

Front Oncol
Liu P, Fang H, Tang X, Dong Q, Xie T, Feng J.   +5 more
europepmc   +1 more source

Phase II study of 1st-line durvalumab and platinum-etoposide in advanced large-cell neuroendocrine lung carcinoma (aLCNEC). [PDF]

Cancer Immunol Immunother
Dudnik E, Nechushtan H, Rotem O, Hanovich E, Wollner M, Boikaner T, Fridman N, Ofer J, Ben-David MA, Reinhorn D.   +9 more
europepmc   +1 more source

Proteomic analysis of LCNEC, SCLC and LCC from FFPE and validation by IHC

Abstracts for Annual Meeting of Japanese Proteomics Society, 2010
openaire   +2 more sources

Triple-Component Lung Carcinoma Diagnosed After Nondiagnostic EBUS: A Case Report. [PDF]

Cureus
Le W, Tirupathi M, Oh L, Diaz M, Tirupathi S.   +4 more
europepmc   +1 more source